Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke

Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke

Inflammation following ischemic brain injury is correlated with adverse outcome. Preclinical studies indicate that treatment with acetylsalicylic acid + extended-release dipyridamole (ASA + ER-DP) has anti-inflammatory and thereby neuroprotective effects by inhibition of monocyte chemotactic protein...

Full description

Bibliographic Details
Main Authors:	Karin Weissenborn, Ralf Lichtinghagen, Hans Worthmann, Reinhard Dengler, Wolfgang G. Eisert, Andreas Schwartz, Helmut Schumacher
Format:	Article
Language:	English
Published:	MDPI AG 2012-07-01
Series:	International Journal of Molecular Sciences
Subjects:	ischemic stroke monocyte chemoattractant protein-1 (MCP-1) antithrombotic therapy neuroprotection dipyridamole acetylsalicylic acid (ASA)
Online Access:	http://www.mdpi.com/1422-0067/13/7/8670

Similar Items

Assessing the variability and the role of inflammatory cytokines and monocyte chemoattractant protein-1 (MCP-1) in predicting stroke among hypertensives: A case-control study
by: Samuel Asamoah Sakyi, et al.
Published: (2022-12-01)

Case Series about the Changed Antiplatelet Protocol for Carotid Endarterectomy in a Teaching Hospital: More Patients with Complications?
by: Martijn S. Marsman, et al.
Published: (2018-10-01)

Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer
by: Lund M, et al.
Published: (2022-02-01)

Monocyte Chemoattractant Protein-1 (MCP-1), Activin-A and Clusterin in Children and Adolescents with Obesity or Type-1 Diabetes Mellitus
by: Eirini Kostopoulou, et al.
Published: (2024-02-01)

Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
by: Bancha Satirapoj, et al.
Published: (2018-09-01)

Discovery of IL‐8/CXCL8 (the story from Frederick)
by: Teizo eYoshimura
Published: (2015-06-01)

Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women
by: Seong-Kyu Lee
Published: (2017-12-01)

Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes via Epigenetic Mechanisms in Coronary Heart Disease
by: Sujie Jia, et al.
Published: (2019-11-01)

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
by: Preethi Radhakrishnan, et al.
Published: (2014-01-01)

Evaluation of Monocyte Chemoattractant Protein-1 levels as diagnostic biomarker of Diabetic Retinopathy.
by: Shabir Ahmed, et al.
Published: (2022-02-01)

Effect of Flavonoids on MCP-1 Expression in Human Coronary Artery Endothelial Cells and Impact on MCP-1-Dependent Migration of Human Monocytes
by: Lea Brüser, et al.
Published: (2023-11-01)

Phagocyte Chemoattraction Is Induced through the Mcp-1–Ccr2 Axis during Efferocytosis
by: Sang-Ah Lee, et al.
Published: (2021-11-01)

Pharmacological Inhibition of CCR2 Signaling Exacerbates Exercise-Induced Inflammation Independently of Neutrophil Infiltration and Oxidative Stress
by: Takaki Tominaga, et al.
Published: (2021-12-01)

The crosstalk between insulin resistance, systemic inflammation, redox imbalance and the thyroid in subjects with obesity
by: Nicoleta Răcătăianu, et al.
Published: (2021-04-01)

Urinary epidermal growth factor and monocyte chemotactic protein-1 as biomarkers of renal injury in patients with obstructed nephropathy
by: Eman M. El-Dydamony, et al.
Published: (2022-12-01)

The Diagnostic Value of Monocyte Chemoattractant Protein-1, Compared with Procalcitonin, C-reactive Protein, and Lactate in Bacteremia Estimation for Patients with Febrile Neutropenia
by: Ödemiş İlker, et al.
Published: (2020-10-01)

Monocyte-Derived miRNA-1914-5p Attenuates IL-1β–Induced Monocyte Adhesion and Transmigration
by: Kohki Toriuchi, et al.
Published: (2023-02-01)

Same Virus, Different Course: The Relationship Between Monocyte Chemoattractant Protein-1 and Surfactant Protein-A Levels And Clinical Course and Prognosis of COVID-19
by: Ferhan KERGET, et al.
Published: (2021-09-01)

Assessment of serum levels of monocyte chemoattractant protein 1 (MCP 1) in patients with periodontitis and atherosclerotic cardiovascular disease
by: Safa A Hamad, et al.
Published: (2022-12-01)

Elevated Levels of Serum IL-17A Secondary to Repeated Intravitreal Injections of Aflibercept in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration
by: Małgorzata Seredyka-Burduk, et al.
Published: (2020-06-01)

Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis
by: Jiapei Wang, et al.
Published: (2018-06-01)

Magnetic Nanoparticles Conjugated with Peptides Derived from Monocyte Chemoattractant Protein-1 as a Tool for Targeting Atherosclerosis
by: Chung-Wei Kao, et al.
Published: (2018-05-01)

Elevated Levels of Monocyte Chemotactic Protein-1 in the Follicular Fluid Reveals Different Populations among Women with Severe Endometriosis
by: Pierre-Emmanuel Bouet, et al.
Published: (2020-05-01)

Role of kidney biomarkers [Kidney injury molecule-1, Calbindin, Interleukin-18 and Monocyte chemoattractant protein-1] in HIV associated pre-eclampsia
by: Soumaya Abdullatif Eltounali, et al.
Published: (2017-10-01)

Mobilization of CD11b+/Ly6chi monocytes causes multi organ dysfunction syndrome in acute pancreatitis
by: Anika Wilden, et al.
Published: (2022-10-01)

Association between monocyte chemoattractant protein-1 -2518 A/G gene polymorphism and the outcome of the nonsurgical periodontal treatment
by: Ching-Wen Chang, et al.
Published: (2018-03-01)

ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE
by: I. S. Yavelov
Published: (2009-03-01)

Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis
by: Supanat Worawichawong, et al.
Published: (2016-12-01)

ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion
by: Li Hailing, et al.
Published: (2012-06-01)

Monocyte chemoattractant protein-1 (MCP1) -2581 A/G and interferon gamma (IFNγ) +874 T/A polymorphisms in Iranian population with pulmonary tuberculosis
by: Ailar Jamali, et al.
Published: (2023-10-01)

-2518A/G polymorphism of monocyte chemotactic protein 1 (MCP-1/CCL2) is associated with cutaneous mastocytosis
by: Hanna Ługowska-Umer, et al.
Published: (2022-01-01)

Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling
by: Xueyan Xi, et al.
Published: (2021-01-01)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
by: Xiangling Wang, et al.
Published: (2020-04-01)

Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in rats
by: Hung Yu-Wen, et al.
Published: (2013-01-01)

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis
by: Tannaz Jamialahmadi, et al.
Published: (2022-11-01)

CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES
by: L. V. Matveeva, et al.
Published: (2018-09-01)

Data on early postoperative changes in aqueous monocyte chemoattractant protein-1 levels after phacoemulsification
by: Motofumi Kawai, et al.
Published: (2016-12-01)

Value MCP-1 as predict vascular disturbances
by: Nikitina V.V., et al.
Published: (2010-12-01)

The role of artichoke leaf tincture (Cynara scolymus) in the suppression of DNA damage and atherosclerosis in rats fed an atherogenic diet
by: Natasa Bogavac-Stanojevic, et al.
Published: (2018-01-01)

From Renal Biomarkers to Therapeutic Targets: The Use of Monocyte Chemoattractant Protein 1, Transforming Growth Factor-Beta, and Connective Tissue Growth Factor in Diabetic Nephropathy and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Katrina J Spensley, et al.
Published: (2018-12-01)